Market closed
Akoya BioSciences/$AKYA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Akoya BioSciences
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.
Ticker
$AKYA
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
205
Website
AKYA Metrics
BasicAdvanced
$65M
-
-$1.12
1.32
-
Price and volume
Market cap
$65M
Beta
1.32
52-week high
$4.65
52-week low
$1.01
Average daily volume
170K
Financial strength
Current ratio
2.606
Quick ratio
1.658
Long term debt to equity
1,064.687
Total debt to equity
1,107.913
Interest coverage (TTM)
-3.95%
Management effectiveness
Return on assets (TTM)
-16.86%
Return on equity (TTM)
-180.44%
Valuation
Price to revenue (TTM)
0.787
Price to book
8.49
Price to tangible book (TTM)
-2.55
Price to free cash flow (TTM)
-1.38
Growth
Revenue change (TTM)
-15.48%
Earnings per share change (TTM)
-21.39%
3-year revenue growth (CAGR)
14.14%
3-year earnings per share growth (CAGR)
-12.10%
What the Analysts think about AKYA
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Akoya BioSciences stock.
AKYA Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
AKYA Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
AKYA News
AllArticlesVideos
Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025
GlobeNewsWire·3 days ago
Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore
GlobeNewsWire·4 days ago
Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya
Business Wire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Akoya BioSciences stock?
Akoya BioSciences (AKYA) has a market cap of $65M as of April 27, 2025.
What is the P/E ratio for Akoya BioSciences stock?
The price to earnings (P/E) ratio for Akoya BioSciences (AKYA) stock is 0 as of April 27, 2025.
Does Akoya BioSciences stock pay dividends?
No, Akoya BioSciences (AKYA) stock does not pay dividends to its shareholders as of April 27, 2025.
When is the next Akoya BioSciences dividend payment date?
Akoya BioSciences (AKYA) stock does not pay dividends to its shareholders.
What is the beta indicator for Akoya BioSciences?
Akoya BioSciences (AKYA) has a beta rating of 1.32. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.